Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study
Table 3
Summary of patient characteristics and efficacy outcomes (difference between six-month and baseline scores).
Intervention n = 5
Control n = 5
P-value
Age in years*
44 ± 6.5 (38 to 55)
48 ± 14.9 (30 to 65)
0.63
GCS score*
14.7 ± 5 (14 to 15)
14.2 ± 1.7 (11 to 15)
0.65
Days b/w onset of stroke and randomization*
4 ± 2.44 (1 to 7)
4 ± 0.7 (3 to 5)
0.87
NIHSS score*†
14 ± 3.9 (8 to 19)
11.0 ± 3.39 ( 7 to 15)
0.23
Mean difference of NIHSS from six months to baseline
−7.0
−6.75
0.90
BI score*‡
25 ± 17.67 (5 to 45)
32 ± 21.09 (15 to 55)
0.58
Mean difference of BI from Six months to baseline
51.25
44
0.59
Mean difference of mRS from six months to one month
−0.5
−0.4
0.79
*Figures represent mean ± SD (range) or numbers. †NIHSS scores range from 0 to 42, with higher scores indicating increasing severity. ‡BI scores range from 0 to 100, with lower scores indicating increasing severity. §mRs score range from 0 to 6, with higher scores indicating increasing severity.
